BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is up in trading after the news of positive phase 3 results of its BEMA buprenorphine tests on patients who have previously used opioids. With continued phase 3 success, the company will proceed to apply for its new drug application (NDA) with the Food and Drug Administration (FDA). BioDelivery Sciences International, Inc. (NASDAQ:BDSI) weekly performance is 8.74%. On last trading day company shares ended up $13.06. Analysts mean target price for the company is $17.81. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) distance from 50-day simple moving average (SMA50) is 28.71%.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) said it was a big mover last session, as the company saw its shares rise. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) shares advanced 5.33% in last trading session and ended the day on $4.74. SNTA return on assets is -120.90%. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) quarterly performance is 16.75%.
Genetic Technologies Limited (ADR) (NASDAQ:GENE) is pleased to announce that the number of BREVAGen” test samples received during the quarter ended June 30, 2014 returned to levels achieved in late CY13. Total patient samples received during the quarter were 1,096, representing 37% growth over the March 2014 quarter (800 samples). Genetic Technologies Limited (ADR) (NASDAQ:GENE) shares moved up 11.28% in last trading session and was closed at $1.14, while trading in range of $1.11 – $1.31. Genetic Technologies Limited (ADR) (NASDAQ:GENE) year to date (YTD) performance is -20.28%.
On 18 JUNE NeoGenomics, Inc. (NASDAQ:NEO) announced that it plans to release its second quarter 2014 financial results on Thursday July 17, 2014. NeoGenomics, Inc. (NASDAQ:NEO) ended the last trading day at $4.06. Company weekly volatility is calculated as 7.54% and price to cash ratio as 37.37. NeoGenomics, Inc. (NASDAQ:NEO) showed a positive weekly performance of 23.03%.